Phibro Animal Health Corporation
USD31.54
-0.28 (-0.86%)
CEO
Jack Clifford Bendheim
IPO Date
2014-04-11
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$31.94
Prev. Close
$31.81
Day Low
$30.98
Day High
$31.94
52W Low
$25.34
52W High
$60.08
Market Cap
$1.28B
Volume
0.10M
| 285.7 |
| 30 Jun 2023 | FY | 30.5% | 3.3% | 11.5% | 3.4% | 1.81 | 3.33 | 17.0 |
| 30 Jun 2022 | FY | 30.3% | 5.2% | 18.7% | 5.3% | 1.79 | 2.97 | 15.8 |
| 30 Jun 2021 | FY | 32.6% | 6.5% | 22.8% | 6.5% | 1.79 | 3.04 | 21.5 |
| 30 Jun 2020 | FY | 32.1% | 4.2% | 17.8% | 4.3% | 2.18 | 2.87 | 31.7 |
| 30 Jun 2019 | FY | 32.0% | 6.6% | 25.3% | 7.5% | 1.51 | 3.02 | 23.4 |
| 30 Jun 2018 | FY | 32.5% | 7.9% | 35.1% | 9.7% | 1.69 | 2.90 | 28.5 |
| 30 Jun 2017 | FY | 32.5% | 8.5% | 42.7% | 10.4% | 2.07 | 3.14 | 22.7 |
| 30 Jun 2016 | FY | 31.8% | 11.0% | 91.4% | 13.5% | 3.90 | 3.15 | 8.9 |
| 13.8 |
| 30 Sept 2025 | Q1 | 32.9% | 7.3% | 8.5% | 1.9% | 2.52 | 3.09 | 15.5 |
| 30 Jun 2025 | Q4 | 29.0% | 4.5% | 6.0% | 1.3% | 2.67 | 2.76 | 15.0 |
| 31 Mar 2025 | Q3 | 30.1% | 6.0% | 7.8% | 1.6% | 2.89 | 2.91 | 10.4 |
| 31 Dec 2024 | Q2 | 32.9% | 1.0% | 1.3% | 0.2% | 3.20 | 3.20 | 66.8 |
| 30 Sept 2024 | Q1 | 32.1% | 2.7% | 2.7% | 0.7% | 1.98 | 3.23 | 32.7 |
| 30 Jun 2024 | Q4 | 31.9% | 0.3% | 0.3% | 0.1% | 2.05 | 2.94 | 229.5 |
| 31 Mar 2024 | Q3 | 30.2% | 3.2% | 3.1% | 0.9% | 1.94 | 3.16 | 15.2 |
| 31 Dec 2023 | Q2 | 31.5% | 0.5% | 0.5% | 0.1% | 1.89 | 3.12 | 92.0 |